D-18F-fluoromethyl tyrosine imaging of bone metastases in a mouse model.

@article{ZitzmannKolbe2010D18FfluoromethylTI,
  title={D-18F-fluoromethyl tyrosine imaging of bone metastases in a mouse model.},
  author={Sabine Zitzmann-Kolbe and Anne Strube and Anna-Lena Frisk and Sanna-Maria K{\"a}k{\"o}nen and Hideo Tsukada and Peter Hauff and Dietmar Berndorff and Keith Graham},
  journal={Journal of nuclear medicine : official publication, Society of Nuclear Medicine},
  year={2010},
  volume={51 10},
  pages={1632-6}
}
UNLABELLED The presence and localization of metastatic bone lesions is important for the staging of the disease and subsequent treatment decisions. Detecting tumor cells would have additional value over the current indirect bone scintigraphy method for detecting areas of elevated skeletal metabolic activity. d-(18)F-fluoromethyl tyrosine (d-(18)F-FMT) has recently shown good uptake and fast elimination, resulting in good tumor-to-background ratios. The potential of d-(18)F-FMT for imaging bone… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-7 of 7 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 22 references

Development and characterization of a new renal cell carcinoma (RCC) bone metastasis mouse model

  • A Strube, E Stepina, B Hartmann, I Neumann, P Hauff, S P14.Kaekoenen
  • Cancer Treat Rev
  • 2008
Highly Influential
6 Excerpts

P 14 . Development and characterization of a new renal cell carcinoma ( RCC ) bone metastasis mouse model

  • A Strube, E Stepina, B Hartmann, I Neumann, P Hauff, S Kaekoenen
  • Cancer Treat Rev
  • 2008

Similar Papers

Loading similar papers…